Clinical Trial Update: Renal Biomarkers in AKI and COVID-19

View source ↗

Summary

Completed clinical trial evaluating renal biomarkers in patients with acute kidney injury and COVID-19.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury
• Respiratory Syndrome

Snippet

Sponsor: Instituto Nacional de Enfermedades Respiratorias | Conditions: Coronavirus Infection, Covid19 | Status: COMPLETED